Abiopharma

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Changes in Interest of Director - Koh Wee Seng

Net Asset Value(s)

PPG appoints John Smith to vice president, architectural coatings EMEA; Steve Pocock to retire

WiMi Explores Multi-Dimensional Pooling Optimization Technology under the Variational Quantum Algorithm Framework

V Gallant’s Fintech Partner Credilab Secures Full Online Lending Approval in Malaysia, Advancing Revenue-Share AI Lending Platform

Nexera Technologies: Subsidiary Fort Technology Commences Trading on Nasdaq Under Ticker “FRTT” Today

AIM ImmunoTech Reports Positive Mid-Year Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZenecas Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer

AIM ImmunoTech Reports Positive Mid-Year Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer

Foresight Secures $17.5 Million Strategic Investment from VisionWave at a $34 Million Valuation Post Investment to Advance AI Perception Capabilities for Defense and Security

Consolidated Water Appoints Water Industry Veteran Sachin Chawla as Senior Vice President, Strategy and Growth